Glioma patients with higher expression of CDHR1 had longer overall survival than glioma patients with lower expression of CDHR1 in all TCGA, CGGA, GSE4412 and GSE43378 datasets (Fig. 3B). Here, CDHR1 is linked to central nervous system cancer.